NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

CompletedN/A

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Conditions: Renal Cell Carcinoma Stage IV

Interventions: mHealth Smart Phone Application, eHEALS digital literacy test, Weekly Quiz, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire, Patient Post Intervention Survey

Countries: United States

The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with Stage IV Renal Cell Carcinoma
* Within 3 weeks from starting combination immune checkpoint blockade with tyrosine kinase inhibitor or multikinase inhibitor
* Estimated survival of 6 months or more
* Able to read and speak English

Exclusion Criteria:

* Unable to read or speak English
* Enrolled in another clinical trial

Locations (1)

Tampa, Florida, United States